Word

Status

Registered

Status Code

700

Status Date

Tuesday, April 9, 2024

Serial Number

97898941

Registration Number

7355281

Registration Date

Tuesday, April 9, 2024

Mark Type

2000

Filing Date

Thursday, April 20, 2023

Published for Opposition

Tuesday, January 23, 2024

Trademark Owner History

Hepalink USA Inc. - Owner At Publication

Classifications

40 Manufacturing services for others in a cGMP ("Current Good Manufacturing Practice") compliant facility in the field of therapeutic compounds, namely, the extraction, isolation and purification of naturally derived and fermentation-derived therapeutic compounds

5 Pharmaceutical products and preparations containing active pharmaceutical ingredients, namely, pharmaceutical grade Heparin Sodium, pharmaceutical grade Pancreatin, and pharmaceutical grade Pancrealipase, for use in humans and animals for the prevention and treatment of thrombotic events or to treat pancreatic insufficiency and related diseases; Pharmaceutical products and preparations, namely, anticoagulants; pharmaceutical products and preparations for the testing, sampling and identification of viruses, namely, medical diagnostic reagents and assays for testing of body fluids; Chemical preparations for sanitary use; Chemical preparations for treating mildew; Diagnostic preparations for medical purposes; Injectable pharmaceuticals for treatment of anaphylactic reactions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for treating thyroid conditions; Pharmaceutical preparations for wounds; Diagnostic preparations for use with medical devices; Pharmaceutical preparations for treating thrombotic events and pancreatic insufficiency for use with medical devices for drug delivery; Pharmaceutical preparations for ophthalmological use, namely, for treating eye diseases and disorders

42 Pharmaceutical contract development in a cGMP ("Current Good Manufacturing Practice") compliant facility in the field of therapeutic compounds, namely, the extraction, isolation and purification of naturally derived and fermentation-derived therapeutic compounds

The mark consists of a stylized design made up of a plurality of solid circles of varying sizes arranged in an hourglass -like shape.
Color is not claimed as a feature of the mark.

Trademark Events

Apr 9, 2024

Registered-Principal Register

Apr 9, 2024

Notice Of Registration Confirmation Emailed

Jan 23, 2024

Official Gazette Publication Confirmation E-Mailed

Jan 23, 2024

Published For Opposition

Jan 3, 2024

Notification Of Notice Of Publication E-Mailed

Dec 15, 2023

Approved For Pub - Principal Register

Dec 12, 2023

Examiner's Amendment Entered

Dec 12, 2023

Notification Of Examiners Amendment E-Mailed

Dec 12, 2023

Examiners Amendment E-Mailed

Dec 12, 2023

Examiners Amendment -Written

Nov 20, 2023

Notification Of Final Refusal Emailed

Nov 20, 2023

Final Refusal E-Mailed

Nov 20, 2023

Final Refusal Written

Oct 10, 2023

Teas/Email Correspondence Entered

Oct 10, 2023

Correspondence Received In Law Office

Oct 10, 2023

Teas Response To Office Action Received

Aug 7, 2023

Notification Of Non-Final Action E-Mailed

Aug 7, 2023

Non-Final Action E-Mailed

Aug 7, 2023

Non-Final Action Written

Jul 28, 2023

Assigned To Examiner

May 19, 2023

Notice Of Design Search Code E-Mailed

May 18, 2023

New Application Office Supplied Data Entered

Apr 24, 2023

New Application Entered